CIK: 1661254 - Address: Lilly Corporate Center, Indianapolis, IN 46285
38 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/2/24 16:22
2/1/24
LLYEli Lilly & CoINHealthDrugPharmaceutical PreparationsVan Naarden JacobINOEVP,P,LoM.d00.00042518D
2/21/23 16:35
2/16/23
LLYEli Lilly & CoINHealthDrugPharmaceutical PreparationsVan Naarden JacobINOEVP,CEO M.d00.00032116D
2/17/22 16:44
2/16/22
LLYEli Lilly & CoINHealthDrugPharmaceutical PreparationsVan Naarden JacobINOSVP,CEO M.d00.00058012D
1/17/19 08:08
7/9/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOCOOM.a63.65021314D
12/12/18 17:17
12/10/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm1499.2901634021D
12/12/18 17:17
12/10/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-1,220135.500-9-3021D
11/28/18 17:13
11/26/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm575.7101027014D
11/28/18 17:13
11/26/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-1,480147.970-10-4214D
10/5/18 16:46
10/3/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm363.6501027014D
10/5/18 16:46
10/3/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-1,651165.130-10-4214D
9/14/18 18:14
9/12/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm363.6501027014D
9/14/18 18:14
9/12/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-1,663166.320-10-4214D
8/15/18 17:27
8/13/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm363.6501027014D
8/15/18 17:27
8/13/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-1,593159.350-10-4214D
7/11/18 17:03
7/9/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm113.65032914D
7/11/18 17:03
7/9/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-566183.500-3-1814D
6/21/18 17:03
6/19/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm553.6501512D
6/21/18 17:03
6/19/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-549178.140-3-2012D
5/16/18 16:46
5/14/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm113.65030D
5/16/18 16:46
5/14/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-424137.420-3-1000D
4/26/18 16:32
4/24/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm113.65030D
4/26/18 16:32
4/24/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-404131.230-3-1000D
3/15/18 17:01
3/13/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm113.65030D
3/15/18 17:01
3/13/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-405131.410-3-1000D
2/14/18 17:35
2/12/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm113.65030D
2/14/18 17:35
2/12/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-29796.340-3-1000D
1/18/18 17:02
1/16/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm113.65030D
1/18/18 17:02
1/16/18
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-27288.210-3-1000D
12/18/17 17:42
12/14/17
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm113.65030D
12/18/17 17:42
12/14/17
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-25081.190-3-1000D
11/29/17 17:21
11/27/17
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm113.65030D
11/29/17 17:21
11/27/17
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-23074.500-3-1000D
11/1/17 17:06
10/30/17
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm113.65030D
11/1/17 17:06
10/30/17
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-26886.890-3-1000D
9/20/17 17:05
9/18/17
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm113.65030D
9/20/17 17:05
9/18/17
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-27489.000-3-1000D
8/16/17 17:22
8/14/17
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuM.dm113.65030D
8/16/17 17:22
8/14/17
LOXOLoxo Oncology, Inc.DEHealthDrugPharmaceutical PreparationsVan Naarden JacobCTOChief BuS.dm-22773.570-3-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact